Literature DB >> 25196572

Realgar nanoparticle-based microcapsules: preparation and in-vitro/in-vivo characterizations.

Feng Shi1, Nianping Feng, Emmanuel Omari-Siaw.   

Abstract

OBJECTIVES: The aim of this study was to prepare microcapsules for the oral delivery of realgar nanoparticles (RN) that are also capable of improving its stability.
METHODS: RN and RN-based microcapsules (RNM) were prepared using ball milling and solvent evaporation techniques, respectively. Properties such as particle size, ζ-potential (ZP), morphology and X-ray diffractometer (XRD) were investigated. In addition, drug release, bioavailability and antitumour studies were also performed. KEY
FINDINGS: The nanoparticles appeared round or elliptical in shape with a mean size of 85.4 ± 3.5 nm and a ZP of -34.3 ± 1.7 mV. The obtained RNM appeared spherical and not aggregated with a relatively narrow size distribution. XRD analysis revealed that ball milling technique did not change the crystallinity of the realgar powder. RN and RNM exhibited considerable higher release of As2 S2 , bioavailability and antitumour efficacies compared with crude realgar. Furthermore, RNM could protect RN directly exposed to the air and light, and therefore increased the stability of the RN.
CONCLUSIONS: The developed RNM demonstrated a greater potential as a delivery system for realgar.
© 2014 Royal Pharmaceutical Society.

Entities:  

Keywords:  antitumour efficacy; bioavailability; in-vitro release; microcapsules; realgar nanoparticles

Mesh:

Substances:

Year:  2014        PMID: 25196572     DOI: 10.1111/jphp.12314

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  4 in total

1.  Acid Water-ground Nano-realgar Is Superior to Crude Realgar in Promoting Apoptosis of MCF-7 Breast Cancer Cells.

Authors:  Juan Xi; Jia-Hui Fang; Xiao-Mei Xiong; Chun Gui; Yu-Xue Wang; Xiu-Qiao Zhang
Journal:  Curr Med Sci       Date:  2022-07-05

Review 2.  Properties of realgar bioleaching using an extremely acidophilic bacterium and its antitumor mechanism as an anticancer agent.

Authors:  Peng Chen; Ruixiang Xu; Lei Yan; Zhengrong Wu; Yan Wei; Wenbin Zhao; Xin Wang; Qinjian Xie; Hongyu Li
Journal:  Biol Res       Date:  2017-05-22       Impact factor: 5.612

3.  Realgar (As4S4), a traditional Chinese medicine, induces acute promyelocytic leukemia cell death via the Bcl-2/Bax/Cyt-C/AIF signaling pathway in vitro.

Authors:  Zonghong Li; Ruiming Zhang; Xuewei Yin; Nana Li; Siyuan Cui; Teng Wang; Xing Tan; Mingyue Shen; Yun Guo; Jinxin Wang; Dadong Guo; Ruirong Xu
Journal:  Aging (Albany NY)       Date:  2022-09-12       Impact factor: 5.955

4.  Fabrication of water-soluble polymer-encapsulated As4S4 to increase oral bioavailability and chemotherapeutic efficacy in AML mice.

Authors:  Qiang Ma; Chuan Wang; Xiaojin Li; Hua Guo; Jie Meng; Jian Liu; Haiyan Xu
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.